Hematopoietic stem cell transplantation in Griscelli syndrome type 2: A single-center report on 10 patients

Blood

Volumn 114, Issue 1, 2009, Pages 211-218

  Schmid, Jana Pachlopnik ^a,b,c   Moshous, Despina ^a,b,c   Boddaert, Nathalie ^c   Neven, Bénédicte ^a,b,c   Dal Cortivo, Liliane ^c   Tardieu, Marc ^d   Cavazzana Calvo, Marina ^c   Blanche, Stéphane ^c   De Saint Basile, Geneviève ^a,b,c   Fischer, Alain ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CD20 ANTIBODY; CD52 ANTIBODY; COMPLEMENTARY DNA; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; GENOMIC DNA; HYDROCORTISONE; IMMUNOGLOBULIN; ITRACONAZOLE; LYMPHOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHOTREXATE; PREDNISONE; RAB27A PROTEIN; RITUXIMAB; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADD ON THERAPY; ADULT RESPIRATORY DISTRESS SYNDROME; APLASIA; AREFLEXIA; ARTICLE; ATAXIA; BONE NECROSIS; BRAIN EDEMA; BRAIN HEMORRHAGE; CAPILLARY LEAK SYNDROME; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DISSEMINATED INTRAVASCULAR CLOTTING; EPILEPSY; EPSTEIN BARR VIRUS; FACIAL NERVE PARALYSIS; FEMALE; FEMUR; GENE MUTATION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; GRISCELLI SYNDROME; GRISCELLI SYNDROME TYPE 2; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMORRHAGIC CYSTITIS; HERPES SIMPLEX; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION PREVENTION; LUNG HEMORRHAGE; LYMPHOPROLIFERATIVE DISEASE; MALE; NEUROLOGIC DISEASE; NEWBORN; PANCREATITIS; PAPILLEDEMA; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SOMNOLENCE; SURVIVAL; T CELL DEPLETION; TREATMENT OUTCOME; VEIN OCCLUSION; VOMITING; WHITE MATTER; ALLOTRANSPLANTATION; BRAIN; GENETICS; GRAFT SURVIVAL; IMMUNOLOGY; INFANT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; SYNDROME; VIRUS INFECTION;

BRAIN; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SYNDROME; TRANSPLANTATION, HOMOLOGOUS;

EID: 67651056216     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-207845     Document Type: Article

References (45)

1. Griscelli C, Durandy A, Guy-Grand D, Daguillard F, Herzog C, Prunieras M. A syndrome associating partial albinism and immunodeficiency. Am J Med. 1978;65:691-702. (Pubitemid 9039527)
2. Pastural E, Barrat FJ, Dufourcq-Lagelouse R, et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet. 1997;16:289-292. (Pubitemid 27280214)
3. Duran-McKinster C, Rodriguez-Jurado R, Ridaura C, de la Luz Orozco-Covarrubias M, Tamayo L, Ruiz-Maldonando R. Elejalde syndrome-a melanolysosomal neurocutaneous syndrome: clinical and morphological findings in 7 patients. Arch Dermatol. 1999;135:182-186. (Pubitemid 29098365)
4. Menasche G, Ho CH, Sanal O, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest. 2003;112: 450-456. (Pubitemid 38063774)
5. Menasche G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 2000;25:173-176. (Pubitemid 30394987)
6. Menasche G, Feldmann J, Fischer A, de Saint Basile G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev. 2005;203: 165-179. (Pubitemid 40179701)
7. Pachlopnik Schmid J, Ho CH, Diana J, et al. A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). Eur J Immunol. 2008;38:3219-3225.
8. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131. (Pubitemid 44958267)
9. Fischer A, Latour S, de Saint Basile G. Genetic defects affecting lymphocyte cytotoxicity. Curr Opin Immunol. 2007;19:348-353. (Pubitemid 46705487)
10. Stepp SE, Mathew PA, Bennett M, de Saint Basile G, Kumar V. Perforin: more than just an effector molecule. Immunol Today. 2000;21:254-256. (Pubitemid 30333296)
11. Mahlaoui N, Ouachee-Chardin M, de Saint Basile G, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics. 2007;120:e622-e628.
12. Schneider LC, Berman RS, Shea CR, Perez-Atayde AR, Weinstein H, Geha RS. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome). J Clin Immunol. 1990;10:146-153.
13. Tezcan I, Sanal O, Ersoy F, et al. Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement. Bone Marrow Transplant. 1999;24:931-933. (Pubitemid 29500358)
14. Schuster F, Stachel DK, Schmid I, et al. Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant. 2001;28:409-412. (Pubitemid 32834362)
15. Arico M, Zecca M, Santoro N, et al. Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29: 995-998. (Pubitemid 34845956)
16. Cesaro S, Locatelli F, Lanino E, et al. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP). Haematologica. 2008;93:1694-1701.
17. Westbroek W, Tuchman M, Tinloy B, et al. A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome. Mol Genet Metab. 2008;94:248-254.
18. Trottestam H, Beutel K, Meeths M, et al. Treatment of the X-linked lymphoproliferative, Griscelli and Chediak-Higashi syndromes by HLH directed therapy. Pediatr Blood Cancer. 2009;52:268-272.
19. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood. 1993;82:2319-2323. (Pubitemid 23304254)
20. Crozat K, Hoebe K, Ugolini S, et al. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med. 2007;204:853-863. (Pubitemid 46631614)
21. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-828.
22. Jones RJ, Lee KS, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44: 778-783. (Pubitemid 18034278)
23. Klein C, Philippe N, Le Deist F, et al. Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr. 1994;125:886-895. (Pubitemid 24379121)
24. Sanal O, Ersoy F, Tezcan I, et al. Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity. J Clin Immunol. 2002;22: 237-243. (Pubitemid 34774987)
25. Aslan D, Sari S, Derinoz O, Dalgic B. Griscelli syndrome: description of a case with Rab27A mutation. Pediatr Hematol Oncol. 2006;23:255-261. (Pubitemid 43361807)
26. Ashrafi MR, Mohseni M, Yazdani S, et al. Bilateral basal ganglia involvement in a patient with Griscelli syndrome. Eur J Paediatr Neurol. 2006;10: 207-209. (Pubitemid 44469308)
27. Mamishi S, Modarressi MH, Pourakbari B, et al. Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot. J Clin Immunol. 2008;28:384-389.
28. Anikster Y, Huizing M, Anderson PD, et al. Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A. Am J Hum Genet. 2002;71:407-414. (Pubitemid 34800257)
29. Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics. 2006;117: e743-e750. (Pubitemid 46071479)
30. Feldmann J, Le Deist F, Ouachee-Chardin M, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002; 117:965-972. (Pubitemid 34639264)
31. Horne A, Ramme KG, Rudd E, et al. Characterization of PRF1, STX11 and UNC13D genotypephenotype correlations in familial hemophagocytic lymphohistiocytosis. Br J Haematol. 2008; 143:75-83.
32. Plebani A, Ciravegna B, Ponte M, Mingari MC, Moretta L. Interleukin-2 mediated restoration of natural killer cell function in a patient with Griscelli syndrome. Eur J Pediatr. 2000;159:713-714. (Pubitemid 30658565)
33. Gazit R, Aker M, Elboim M, et al. NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. Blood. 2007;109:4306-4312. (Pubitemid 46743397)
34. de Saint Basile G. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. 2nd Ed. New York, NY: Oxford University Press; 2007.
35. Kamble RT, Chang CC, Sanchez S, Carrum G. Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant. 2007;39:49-52. (Pubitemid 44921654)
36. Chen D, Guo J, Miki T, Tachibana M, Gahl WA. Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med. 1997;60:27-37. (Pubitemid 27198147)
37. Tardieu M, Lacroix C, Neven B, et al. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood. 2005;106:40-42. (Pubitemid 40967172)
38. Rudelius M, Osanger A, Kohlmann S, et al. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration. Acta Neuropathol. 2006;112:267-276. (Pubitemid 44275882)
39. Horne AC, TrottestamH, Arico M, et al. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2007;140:327-335.
40. Jordan MB, Filipovich AH. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant. 2008;42:433-437.
41. Pachlopnik Schmid J, Ho CH, Chretien F, et al. Neutralization of IFNγ defeats hemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med. 2009, DOI: 10.1002/emmm.200900009:112-124.
42. Baker KS, DeLaat CA, Steinbuch M, et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood. 1997;89:3857-3863. (Pubitemid 27227112)
43. Rottman M, Soudais C, Vogt G, et al. IFN-γ mediates the rejection of haematopoietic stem cells in IFN-γR1-deficient hosts. PLoS Med. 2008;5:e26.
44. Milone MC, Tsai DE, Hodinka RL, et al. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood. 2005;105:994-996.
45. Cooper N, Rao K, Gilmour K, et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood. 2006;107:1233-1236. (Pubitemid 43156331)